Related Experiment Video
Updated: Mar 8, 2026

Utilizing Time-Resolved Protein-Induced Fluorescence Enhancement to Identify Stable Local Conformations One α-Synuclein Monomer at a Time
Published on: May 30, 2021
Structural Characteristics of α-Synuclein Oligomers.
N Cremades1, S W Chen2, C M Dobson2
1Biocomputation and Complex Systems Physics Institute (BIFI)-Joint Unit BIFI-IQFR (CSIC), Universidad de Zaragoza, Zaragoza, Spain.
Oligomeric forms of alpha-synuclein (α-synuclein) are implicated in Parkinson's disease pathogenesis. This review clarifies their diverse structures and formation, crucial for developing diagnostics and therapeutics.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Oligomeric amyloid aggregates are detected in neurodegenerative disorders like Parkinson's disease.
- These species are considered key pathogenic agents but are challenging to study due to their transient and heterogeneous nature.
- Understanding oligomer structure and formation is vital for identifying diagnostic and therapeutic targets.
Purpose of the Study:
- To review current knowledge on the various oligomeric forms of alpha-synuclein (α-synuclein).
- To emphasize the structural features and potential relationships with other amyloid species.
- To build a clearer understanding of α-synuclein aggregation and misfolding behavior.
Main Methods:
- Literature review focusing on reported oligomeric forms of α-synuclein.
- Analysis of structural features and formation mechanisms.
- Comparison with other amyloid species.
Main Results:
- Detailed characterization of multiple α-synuclein oligomeric species.
- Insights into the heterogeneity and transient nature of these toxic species.
- Exploration of the interconversion pathways between different oligomeric states.
Conclusions:
- A comprehensive understanding of α-synuclein oligomers is essential for unraveling Parkinson's disease mechanisms.
- Identifying specific toxic oligomeric species can guide the development of targeted therapies.
- Further research into α-synuclein misfolding and aggregation is critical for future therapeutic strategies.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Protein Organization
Protein Organization
The primary structure of a protein is its amino acid sequence....
Protein Folding
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...

